Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Kiora Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $16.02M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $16.02M | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $12.06K | -99.6% |
| FY2019 | Dec 31, 2019 | $2.69M | +62.5% |
| FY2018 | Dec 31, 2018 | $1.65M | +305.5% |
| FY2017 | Dec 31, 2017 | $407.52K | -39.1% |
| FY2016 | Dec 31, 2016 | $669.26K | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $20.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $16.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $12.06K | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.69M | +145.1% |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $314.50K | +321.0% |
| Q2 FY2018 | Jun 30, 2018 | $242.01K | +63.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.10M | +493.9% |
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $74.70K | -72.8% |
| Q2 FY2017 | Jun 30, 2017 | $148.29K | – |
| Q1 FY2017 | Mar 31, 2017 | $184.53K | – |
| Q4 FY2016 | Dec 31, 2016 | $160.37K | – |
| Q3 FY2016 | Sep 30, 2016 | $274.29K | – |
See a number that looks wrong?